Headwinds primarily associated with Medicare Advantage (MA) and care activity in its insurance business led UnitedHealth Group (UHG) (NYSE: UNH) to lower its anticipated earnings per share for 2025. In the first quarter of 2025, UHG’s revenues increased by $9.8 billion year-over-year, reaching $109.6 billion. This growth was primarily driven by a more comprehensive approach […]
Optum
The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will go to mediation on Aug. 18. The DOJ sued the two companies starting in November of last year to block the UnitedHealth Group subsidiary Optum from acquiring Amedisys due to antitrust concerns. The case will now go […]
On Tuesday, the U.S. House of Representatives passed a continuing resolution that would extend the Centers for Medicare & Medicaid Services (CMS) Hospital-at-Home (HaH) waiver program and telehealth flexibilities through Sept. 30, pending Senate approval. This program, scheduled to end on March 31, enables hospitals to deliver hospital-level care to patients in their homes. However, […]
UnitedHealthcare is eliminating prior authorization requirements for certain home health services provided under Medicare Advantage plans as part of a larger push to cut prior authorization volume by 10% this year. Effective April 1, 2025, the insurance giant—part of UnitedHealth Group (NYSE: UHG)—will no longer require prior authorization or concurrent review processes for home health […]
Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending acquisition by UnitedHealth Group (NYSE: UNH). The company’s home health business reported net service revenues of $377 million for the fourth quarter of 2024, an increase from $358.9 million in the same quarter […]
We’re now about one month away from the end of the hospital-at-home waiver that has been keeping the program alive. With the March 31 deadline fast approaching, the push to further extend the program is picking up steam. Earlier this month, in-home care advocacy group Moving Health Home sent a letter to Congress urging the […]
The year ahead will be a fascinating one in home health care. As 2025 dawns, the industry faces many uncertainties, and the next 12 months will be pivotal in shaping the future. Regulatory decisions will have an outsized impact on home health providers in the near-term, and their effects could stretch well into the future. […]
Amedisys’ (Nasdaq: AMED) planned divestiture of more than 100 home health and hospice locations to VitalCaring has reportedly been halted following a federal court ruling that requires Texas-based VitalCaring to allocate a significant portion of its future profits to Encompass Health and Enhabit. Amedisys in June announced an agreement to sell some of its locations […]
UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) have extended the deadline to finalize their merger agreement until 2025, as stated in a filing on Dec. 27. The merger is currently under close scrutiny by the U.S. Department of Justice (DOJ), which filed a lawsuit on Nov. 12 to block the takeover, labeling it as […]
LHC Group President and CEO Josh Proffitt on Wednesday shared a home-based, value-based vision for the company’s future. UnitedHealth Group’s (NYSE: UNH) Optum acquired LHC Group last year for $5.4 billion. “Home Care remains deeply fragmented, disconnected and too difficult to navigate,” Proffitt said Wednesday. “It accounts for about $150 billion of the health sector […]
Subscribe
Receive industry updates and breaking news from HHCN